Preclinical Symphogen raises €41m of VC cash
This article was originally published in Scrip
Executive Summary
Symphogen, which in 2011 raised €100 million in the largest private financing by a European biotechnology company (scripintelligence.com, 6 January 2011), has expanded that round with another €41 million.